Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus.
D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D004562:Electrocardiography; D005260:Female; D005292:Ferricyanides / Q000008:administration & dosage / Q000627:therapeutic use*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000188:drug therapy* / Q000209:etiology; D009203:Myocardial Infarction / Q000150:complications; D009569:Nitric Oxide / Q000008:administration & dosage / Q000627:therapeutic use; D010701:Phonocardiography; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000627:therapeutic use*
D005292:Ferricyanides; D014665:Vasodilator Agents; D009569:Nitric Oxide